Interactions Between Antiretroviral Drugs and Drugs Used for the Therapy of the Metabolic Complications Encountered During HIV Infection
- 1 January 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 41 (14), 1195-1211
- https://doi.org/10.2165/00003088-200241140-00004
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase InhibitorsClinical Pharmacokinetics, 2001
- Calcium-Antagonist DrugsThe New England Journal of Medicine, 1999
- Pharmacokinetics of AlendronateClinical Pharmacokinetics, 1999
- RosiglitazoneDrugs, 1999
- RitonavirClinical Pharmacokinetics, 1998
- Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 1997
- Losartan PotassiumDrugs, 1996
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 1996
- The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.Circulation, 1982
- The influence of verapamil on serum digoxin concentration.Circulation, 1982